Doxazosin (hydrochloride)
Doxazosin hydrochloride (UK 33274 hydrochloride) is a compound used to inhibit hypertension and prostate hyperplasia, with activity that inhibits postsynaptic α1-adrenoceptors on vascular smooth muscle. Doxazosin hydrochloride can cause vasodilation, thereby reducing peripheral vascular resistance. Doxazosin hydrochloride was found to inhibit the proliferation and migration of hepatic stellate cells in a mouse liver fibrosis model. Doxazosin hydrochloride regulates fibrosis, autophagy, and apoptosis of hepatic stellate cells by activating the PI3K/Akt/mTOR signaling pathway. Doxazosin hydrochloride also blocks autophagic flux and induces apoptosis of hepatic stellate cells[1].
Product Specifications
CAS Number
[70918-01-3]
Product Name Alternative
UK 33274 (hydrochloride)
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Akt
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/doxazosin-hydrochloride.html
Smiles
O=C(C1OC2=C(OC1)C=CC=C2)N3CCN(CC3)C4=NC5=C(C=C(C(OC)=C5)OC)C(N)=N4.Cl
Molecular Formula
C23H26ClN5O5
Molecular Weight
487.94
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Doxazosin Attenuates Liver Fibrosis by Inhibiting Autophagy in Hepatic Stellate Cells via Activation of the PI3K/Akt/mTOR Signaling Pathway
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 4
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items